Agendia BV

Type: Company

Name: Agendia BV

Fact Sheet: Fact Sheet for Agendia BV

First reported 22 hours ago - Updated 20 hours ago - 3 reports

Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions

IRVINE, Calif."We anticipate these innovative social media campaigns will encourage more patients to ask their oncologists and breast surgeons about our Symphony genomic test panel," said David MacdonaldThe website (www.KnowYourBreastCancer.com) provides ... [Published Bio-Medicine - 20 hours ago]

Entities: Agendia BV, Breast Cancer, Chemotherapy, Social Media, Genomics

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Agendia Reports More Than 20,000 MammaPrint Breast Cancer Recurrence Results

/PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that it has reported more than 20,000 MammaPrint breast cancer results, including approximately 6,000 in 2012 alone. The MammaPrint test analyzes 70 key genes and ... [Published FinanzNachrichten.de - May 02 2013]

Entities: Agendia BV, Breast Cancer, Patient, David Macdonald, Genomics

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Molecular Diagnostics in Cancer Testing Report: 2013 Edition

Research and Markets has announced the addition of the "Molecular Diagnostics in Cancer Testing" report to their offering. Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually ... [Published Individual.com - Apr 30 2013]

Entities: Molecular Diagnostics, Cancer, Aureon Laboratories Inc, Orion Genomics LLC

First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Saladax Recruits Top Talent as Commercial Introduction of MyCare(TM) Portfolio of Oncology Diagnostics Nears

/PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, today announced it has appointed Jonathan Mayo ... [Published NewsBlaze - Apr 18 2013]

Entities: Oncology, Diagnostics, Impath Inc

First reported Jan 25 2013 - Updated Jan 25 2013 - 2 reports

Agendia Appoints Dr. Neil M. Barth MD FACP as Chief Medical Officer

Home » Syndicated Content » Agendia Appoints Dr. Neil M. Barth MD, FACP, as Chief Medical OfficerIRVINE, Calif. and AMSTERDAM , Jan. 25, 2013 /- Agendia, a world leader in molecular cancer diagnostics, today announced the addition of Dr. Neil M. Barth ... [Published BioPortfolio - Jan 25 2013]

Entities: Agendia BV, Appointed, Biotechnology, Health Care

First reported Nov 28 2012 - Updated Nov 28 2012 - 1 reports

Agendia BV

Study identifies gene signature associated with resistance to cancer therapies

Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the publication in the November 21st issue of the prestigious scientific journal "Cell" of a study that identifies a gene signature that.. ... [Published BioPortfolio - Nov 28 2012]

Entities: Cancer, Agendia BV

Quotes

"We anticipate these innovative social media campaigns will encourage more patients to ask their oncologists and breast surgeons about our Symphony genomic test panel" said David Macdonald

Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [Published Bio-Medicine - 20 hours ago]

...to ask their oncologists and breast surgeons about our Symphony genomic test panel," said David Macdonald, Agendia's Chief Executive Officer. "Women who have been told they have early stage breast cancer often face a tough decision regarding whether or not they should have chemotherapy after surgery. They are looking for current, easily understood information to support their decision. As many women have already told us, the new website and Facebook page achieve that important goal."

Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decision ... [Published Yahoo! Finance - 22 hours ago]

...RASTER study shows that MammaPrint accurately identifies half of breast cancer patients who can safely forgo chemotherapy with excellent outcome. "That data has given physicians and oncologists throughout the world confidence in the ability of MammaPrint to determine risk, and to guide therapeutic choices."

Agendia Reports More Than 20,000 MammaPrint Breast Cancer Recurrence Results [Published FinanzNachrichten.de - May 02 2013]

...we are very pleased to have Michael onboard to ensure the highest quality of operations at Saladax Biomedical Laboratories," said Mark Myslinski. "Michael's strong grounding in analytical chemistry and broad experience in laboratory development, commercialization and management makes him well suited for this role."

Saladax Recruits Top Talent as Commercial Introduction of MyCare(TM) Portfolio of Oncology Diagno ... [Published NewsBlaze - Apr 18 2013]

More Content

sort by: Date \| Relevance
Agendia Launches Social Media Campaigns to Help... [Published Bio-Medicine - 20 hours ago]
Agendia Launches Social Media Campaigns to Help... [Published Yahoo! Finance - 22 hours ago]
Agendia Launches Social Media Campaigns to Help... [Published Street Insider - 22 hours ago]
Agendia Launches Social Media Campaigns to Help... [Published PR Newswire: Health - 22 hours ago]
Molecular Diagnostics In Cancer Testing [Published TheStreet.com - May 22 2013]
Agendia Reports More Than 20,000 MammaPrint Bre... [Published FinanzNachrichten.de - May 02 2013]
Agendia Reports More Than 20,000 MammaPrint Bre... [Published PR Newswire: Health - May 02 2013]
Molecular Diagnostics in Cancer Testing Report:... [Published Individual.com - Apr 30 2013]
Saladax Recruits Top Talent as Commercial Intro... [Published NewsBlaze - Apr 18 2013]
The Jackson Laboratory for Genomic Medicine, Co... [Published Pharmaceutical Technology - Mar 09 2013]
Agendia Appoints Dr. Neil M. Barth MD FACP as C... [Published BioPortfolio - Jan 25 2013]
Agendia Appoints Dr. Neil M. Barth MD, FACP, as... [Published Business Technology - Jan 25 2013]
Study identifies gene signature associated with... [Published BioPortfolio - Nov 28 2012]
Agendia announces discovery of a gene signature... [Published PR Newswire: Health - Nov 27 2012]
Agendia Announces Five Studies in Breast Cancer... [Published PR Newswire - Sep 13 2012]
Rubicon's NovaPLEX family of sample preparation... [Published PharmaBiz - Aug 16 2012]
Fact Sheet for Agendia BV [Published Able2Act - Jun 27 2006]

Press Releases

sort by: Date \| Relevance
Agendia Launches Social Media Campaigns to Help... [Published PR Newswire: Health - 22 hours ago]
Agendia Reports More Than 20,000 MammaPrint Bre... [Published PR Newswire: Health - May 02 2013]
Agendia announces discovery of a gene signature... [Published PR Newswire: Health - Nov 27 2012]
Agendia Announces Five Studies in Breast Cancer... [Published PR Newswire - Sep 13 2012]